Opexa Therapeutics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical research and analysis.
The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.
“The results of the preclinical animal study provide evidence that T-cell immunotherapy reduces the level of activated ARTC in a murine (mouse) model.” Read the following article
Opexa Therapeutics, Inc. (Opexa), incorporated on March 15, 1991, is a biopharmaceutical company. The Company is engaged in the development of a personalized immunotherapy with the potential to treat various illnesses, including multiple sclerosis (MS), as well as other autoimmune diseases, such as neuromyelitis optica (NMO). These therapies are based on the Company’s T-cell technology. [Source: Reuters]
Company Website: http://www.opexatherapeutics.com